Serum Institute of India Ltd., a global producer of vaccines, hopes to hear from Gavi, the vaccine alliance, by May this year on whether its $2 alternative to existing pneumococcal conjugate vaccines (PCV) which cost $3 per dose, will be considered for inclusion in its immunization programs.
“We have submitted everything required and between one to three months, we should come to know if we will get...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
